All In Biotech

Drug Trial Radar · NCT00092963

Study to Test an Approved Product in the Early Treatment of Migraine (0462-065)

A Multicenter, Double-Blind, Randomized, Parallel, Placebo-Controlled Study to Examine the Efficacy of Rizatriptan 10 mg Tablet Administered Early During a Migraine Attack While the Pain is Mild

Last checked: Nov 19, 2026Latest source record: Aug 14, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 529 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

529

Actual

Start

Aug 17, 2004

Primary completion

Jan 14, 2005

Study completion Jan 14, 2005

Sponsor

Lead sponsor
Organon and CoIndustry
Sponsor type
Industry
First posted
Sep 29, 2004

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to test the effectiveness of an approved drug in the early treatment of migraine while the pain is still mild.

Conditions

  • Migraine

Interventions

  • MK0462, rizatriptan benzoate / Duration of Treatment: 1dayDrug

  • Comparator: placebo / Duration of Treatment: 1 dayDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of patients who are pain free at 2 hours postdose.
  2. Tolerability as measured by subjective adverse experience reporting.

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.